In addition, DC3-activated CD103+ CD8+ T cells expressed core components of the cytotoxic machinery (PRF1 and GZMA), as reported earlier for breast cancer-invading TRM cells (Figure 7E; Savas et al., 2018). This evidence concerns the gene CD8A and breast carcinoma.